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The polycomb transcriptional repressor Bmi1 promotes cell cycle progression, controls cell senescence, and is implicated in brain
development. Loss of Bmi1 leads to a decreased brain size and causes progressive ataxia and epilepsy. Recently, Bmi1 was shown to
control neural stem cell (NSC) renewal. However, the effect of Bmi1 loss on neural cell fate in vivo and the question whether the action of
Bmi1was intrinsic to theNSCs remained tobe investigated.Here,we show thatBmi1 is expressed in the germinal zone in vivo and inNSCs
aswell as inprogenitors proliferating in vitro, but not indifferentiated cells. Loss ofBmi1 led to adecrease inproliferation in zones known
to containprogenitors: thenewborn cortex and thenewbornandadult subventricular zone. This decreasewas accentuated in vitro, where
we observed a drastic reduction inNSC proliferation and renewal because of NSC-intrinsic effects of Bmi1 as shownby themeans of RNA
interference. Bmi1/ mice also presented more astrocytes at birth, and a generalized gliosis at postnatal day 30. At both stages,
colocalization of bromodeoxyuridine andGFAPdemonstrated thatBmi1 loss did not prevent astrocyte precursor proliferation. Support-
ing these observations, Bmi1/ neurospheres generate preferentially astrocytes probably attributable to a different responsiveness to
environmental factors. Bmi1 is therefore necessary for NSC renewal in a cell-intrinsic mode, whereas the altered cell pattern of the
Bmi1/ brain shows that in vivo astrocyte precursors can proliferate in the absence of Bmi1.
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Introduction
During embryogenesis, neural stem cells (NSCs) participate in
brain formation. First, the NSC population expands. Next, NSCs
generate successive waves of neural precursors in a temporal and
coordinate manner (Zhu et al., 1999; Caviness et al., 2000); then
starting at embryonic day 18 (E18), NSCs give rise to astrocytes
and oligodendrocytes (Marmur et al., 1998). Throughout neuro-
genesis, the NSC pool is maintained by asymmetric stem cell
divisions to generate one stem cell and one committed cell,
whereas the initial expansion of NSCs necessitates symmetric
divisions (Morrison et al., 1997). Several sets of genes are neces-
sary to control NSC renewal by ensuring the maintenance of the
nondifferentiated state,multipotency, survival, quiescence, and a
long-term proliferation potential (for review, see Arsenijevic,
2003). Because Bmi1-deficient mice present a smaller brain after
2 weeks of age, a profound defect in cerebellum growth, and
progressive neurological defects (van der Lugt et al., 1994), Bmi1
could play an important role in brain maintenance and regulate
brain growth through the control of NSC proliferation. Bmi1 is a
transcription factor of the polycomb group acting on the cell
cycle by promoting entry into the S phase through p16ink4a inhi-
bition. Another action of Bmi1 is the depletion of p53 expression
through p19arf repression, leading to a decrease in apoptosis (Ja-
cobs et al., 1999). Bmi1 regulates long-term renewal of fibroblasts
(Jacobs et al., 1999) and was recently described to be essential for
the renewal of adult hematopoietic stemcells (Park et al., 2003). It
was demonstrated that Bmi1 loss leads to impairment in NSC
proliferation and renewal (Molofsky et al., 2003). A recent study
showed that Bmi1 is crucial in the expansion of cerebellar gran-
ular cells both in vivo and in vitro (Leung et al., 2004). However,
the effect of Bmi1 loss in other brain regions remains to be ad-
dressed, as well as the question whether the action of Bmi1 is
intrinsic to the NSCs or attributable to the stem cell niche.
Here, we show that Bmi1 is expressed in the subventricular
zone (SVZ) and in vitro in cortical NSCs as well as in progenitor
cells. We observed a decreased proliferation in the cortex at birth
as well as in the newborn and adult SVZ of Bmi1/ mice. In
accordance with these results, NSCs showed a failure in self-
renewal in vitro. Our results also demonstrate that some environ-
mental factors can partially compensate for Bmi1 loss of func-
tion. Additionally, using an RNA interference approach, we
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provide evidence that the effect of Bmi1 is intrinsic to NSCs and
not resulting from surrounding cells (i.e., the stem cell niche).
Concerning the cell population of the Bmi1/ brain, we ob-
served an increased number of astrocytes at birth and a general-
ized gliosis at postnatal day 30 (P30). The increased astrocytic
population appeared to proliferate normally, as assessed by bro-
modeoxyuridine (BrdU) incorporation. Together, our data show
that Bmi1 is intrinsically required for NSC renewal, leading to a
reduced proliferation in vivo and to an increased astroglial pop-
ulation that retains the ability to proliferate.
Materials andMethods
Animals. The breeding and genotyping of Bmi1/, Bmi1/, and
Bmi1/ mice, on an FVB inbred genetic background, have been han-
dled as described previously (Jacobs et al., 1999).
Brain size evaluation, cell count, and statistics. To evaluate whether a
difference in brain size exists between the genotypes at birth, we mea-
sured the cross-sectional area of the cortex, the striatum, and the SVZ on
four coronal sections per animal (n  4 animals per genotype) taken
from the telencephalon [corresponding to 1.0, 0.7, 0.5, and 0.2mm from
bregma in the adult brain, as defined in themouse brain atlas byHof et al.
(2000)] using the SIS (Mu¨nster, Germany) image analysis system. The
mean cross-sectional areas were calculated from these four samples and
compared between genotypes. The surface of the cortex was measured
from the anterior cingulated cortex to the upper limit of the piriform
cortex, and from the corpus callosum and the external capsule to the
cortical layer 1 included. For the striatum, we measured the surface in-
cluding the caudate–putamen and the nuclei accumbens (core and shell).
Concerning cell count, BrdU-positive or terminal deoxynucleotidyl
transferase-mediated biotinylated UTP nick end labeling (TUNEL)-
positive cells were counted in four 15-m-thick cryosections with the
same brain coordinates as described for the evaluation of brain surfaces.
To quantify the number of labeled cells in the SVZ, the corpus callosum,
and the cortex, the entire region investigated on the section was taken
into account.WequantifiedBrdU- andTUNEL-positive cells in the same
regions as defined for the cross-sectional area measures. Because no dif-
ferences of brain size between genotypes were observed, we expose the
data as the mean number of positive cells per section (mean of the four
slices) for each analyzed region. The cell count in the corpus callosum
included the genu (for the anterior part), the cingulum bundle, and the
external capsule. For cell counts in the adult brains, three sections were
analyzed at 0.5, 0.7, and 0.9 mm from bregma. Concerning the striatum
and cortex, the GFAP-positive cells were counted in 10 random 40
fields, with colocalization with a 4,6-diamidino-2-phenylindole
(DAPI)-positive nucleus as the criterion to identify countable GFAP
cells. For all stainings on histological sections, the counted cell numbers
per section were corrected using Abercrombie’s correction factor (Aber-
crombie, 1946), defined as M/(M  L), where M is the thickness of the
section (15 m) and L is the mean height (diameter) of the counted
nuclei (Abercrombie, 1946). L was measured from several randomly se-
lected 40 fields with an Olympus (Tokyo, Japan) BX60 optical micro-
scope using the SIS image analysis system. Typically, 100 nuclei were
measured for each staining (BrdU, TUNEL, GFAP, and BrdU/GFAP),
each genotype, each region, and each age analyzed. The significance of
the results for the cell counts in vivo and in vitro was assessed by calcu-
lating p values with a two-way ANOVA test when three groups were
compared or by an unpaired t test when two groups were analyzed.
Results are presented as mean SEM. The number of animals and the p
values are specified here for each analysis.
Dissection and primary culture. The cerebral cortex was dissected and
removed from newborn (P0–P1) or E14 mice. The dissection included
all of the dorsal part of the ventricular zone and the SVZ of Bmi1/,
Bmi1/, and Bmi1/mice and was processed as described previously
(Arsenijevic et al., 2001b). Dissociated cells were grown in the presence of
epidermal growth factor (EGF; 20 ng/ml; Peprotech, Rocky Hill, NJ) in
96-well plates (Nunc, Naperville, IL) at a concentration of 5000 cells per
well in 200l ofmedium, corresponding to a density of 15,000 cells/cm2.
The number of spheres was counted after 8–10 d in vitro (DIV). Six to
eight wells were counted for each animal tested.
Renewal and differentiation assays. To evaluate the self-renewal capac-
ity of progenitor cells, individual spheres were transferred into new 96-
well plates with 200 l of growth medium (one sphere per well), visually
checked, and mechanically dissociated. Secondary neurospheres were
counted after 8–10 DIV. Sphere differentiation was performed as de-
scribed previously (Arsenijevic et al., 2001b) with indication here of the
specific substrates used.
Bmi1 silencing experiments. We designed a morpholino oligonucleo-
tide (Gene Tools, Philomath, OR) to bind the Bmi1 mRNA, and a mis-
sense controlmorpholino oligonucleotide, with the following sequences:
5-GCATTTCTGCTTGATAAAAGATCCC-3 and 5-GgATTgTGCTT-
cATAAAAcATgCC-3, respectively. For both primary cultures and re-
newal assays, we plated the cells as described above, adding 0.2–0.7 M
morpholino ormissense and EPEI, removing themix after an incubation
of 3 h at 37°C, and replacing it with fresh growth medium. HIV-
BmiRNAi-GFPwas generated by inserting the cassette containing theH1
promoter and the Bmi target sequence from pRETRO-SUPER-Bmi in
front of the green fluorescent protein (GFP) expression cassette of HIV-
CS-CG (Bmi1 target sequence and cloning details are available on re-
quest). Lentiviruses were produced as described previously (Naldini et
al., 1996) and added to cells dissociated from primary neurospheres, 1 d
after dissociation. Cells were plated at low density (15,000 cells/cm2).
Because transgene expression occurs in48 h and NSC division in 72 h,
we can expect that the Bmi1 silencing vectors act directly in the NSCs. In
another experimental paradigm, performed at higher cell density (50,000
cells/cm2), lentiviral infection was performed at 3 DIV, and the spheres
were transferred at 9 DIV onto poly-ornithin- and laminin-treated cov-
erslips for 24 h to be fixed with 4% paraformaldehyde (PAF) at 10 DIV
after a treatment with the annexin V–cyanine 3 apoptosis detection kit
(Biovision, Mountain View, CA) following the manufacturer’s
instructions.
RNA extraction and reverse transcription-PCR. RNA was isolated from
freshly dissociated neurospheres, reverse transcribed, and amplified with
a previously describedmethod (Jacobs et al., 1999). The primer pair used
for the amplification of the Bmi1 mRNA was 5-CAGCAATGAC-
TGTGATGC-3 (sense) and 5-CTCCAGCATTCGTCAGTC-3 (anti-
sense). The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) re-
verse transcription (RT)-PCR was performed as a control, with the
primer pair for GAPDH being 5-ACCACAGTCCATGCCATCAC-3
(sense) and 5-TCCACCACCCTGTTGCTGTA-3 (antisense).
BrdU labeling and TUNEL detection. Anti-BrdU staining was per-
formed on cryostat brain slices from newborn mice that received intra-
peritoneal injections of BrdU (65 g/g body weight; Boehringer Mann-
heim, Mannheim, Germany) 30 min before being killed or at E18 by
intraperitoneal injection into the pregnant mother. For proliferation
analysis in adult mice, BrdU was injected at P28 and P29, then the mice
were perfusion fixed at P30 for histological analysis. BrdU incorporation
was detected using the protocol from the proliferation detection kit
(BoehringerMannheim)with the antibody listed below.Only bright cells
were counted. TUNEL was performed on cryostat newborn brain slices
with the DeadEnd Colorimetric TUNEL System (Promega, Madison,
WI) following the manufacturer’s directions. Counting of cells positive
for BrdU or the TUNEL assay was undertaken with a double- blind
method. Mouse codes were hidden until after the final count.
Immunocytochemistry and histochemistry. For GFAP, neuron-specific
nuclear protein (NeuN), and nestin labeling, cryostat slices were first
blocked with 10% normal goat serum (NGS) and 0.3% Triton X-100 in
PBS for 1 h at room temperature, and then primary antibodies were
incubated overnight at 4°C. For oligodendrocyte marker (O4) labeling,
slices were treated with 10%NGS without Triton X-100. For Bmi1 label-
ing, after the blocking treatment, the primary antibodywas incubated for
48 h at 4°C. Secondary antibodies were incubated for 1 h at room tem-
perature. DAPI staining was performed by incubating the sections with
the DAPI solution (see below) for 10 min. All slides were rinsed three
times with PBS after, respectively, primary antibody, secondary anti-
body, and DAPI incubations. For cultured cell labeling, cells were first
fixed with 4% PAF for 20 min and processed as described previously
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(Arsenijevic et al., 2001b), with the following
modifications for the anti-Bmi1 and anti-Lex
antibody incubations: the anti-Bmi1 antibody
was incubated for 48 h at 4°C, and the anti-Lex
antibody was used without detergent.
Antibodies. Primary antibodies for indirect
immunochemistry included the following:
mouse IgG monocolonal anti--tubulin iso-
type III antibody (1:1000; Sigma, Buchs, Swit-
zerland), rabbit anti-GFAP antiserum (1:400;
Dako, High Wycombe, UK), mouse IgM
monoclonal anti-O4 antibody (1:50; Chemi-
con, Temecula, CA), mouse IgG monoclonal
anti-BrdU antibody RPN202 (1:3; Amersham
Biosciences, Buckingamshire, UK), mouse F6
monoclonal anti-Bmi1 antibody (1:40)
(Alkema et al., 1997), rabbit polyclonal anti-
nestin antibody 130 (1:500; a generous gift from
R. D. G. McKay, National Institutes of Health,
Bethesda, MD) (Tohyama et al., 1992), and
mouse IgM monoclonal anti-LeX antibody
(1:200; BD Biosciences, Franklin Lake, NJ).
The secondary antibodies (Jackson Immuno-
Research, West Grove, PA) were as follows:
cyanine-conjugated, affinity-purified goat anti-
body to mouse IgG (1:1000), FITC-conjugated
affinity-purified goat antibody tomouse IgG (1:
100), and 7-amino-4-methylcoumarin-3-acetic
acid- or cyanine-conjugated, affinity-purified
goat antibody to mouse IgM (1:100 and 1:400,
respectively). DAPI (0.3m;Molecular Probes,
Eugene, OR) was used for counterstaining.
Results
Bmi1 and body growth
The loss of Bmi1 has no significant consequence on body weight
at birth, as reported previously (van der Lugt et al., 1994;
Molofsky et al., 2003), with the mean body weight 1.36  0.10,
1.43  0.09, and 1.40  0.09 g, respectively for Bmi1/,
Bmi1/, and Bmi1/ newborn mice (n 6). It is important to
underscore that the forebrain of newborn Bmi1/ mice also is
not different in size at birth compared with the other genotypes,
whereas it is decreased in the young adult Bmi1/ mice only.
Indeed, at birth, the cross-sectional area of several regions of the
telencephalonmeasured at four different levels (seeMaterials and
Methods) showed no significant variation between genotypes
(supplemental Fig. 1, available at www.jneurosci.org as supple-
mental material). The cortex, striatum, corpus callosum, and
SVZ showed no significant differences between groups, indicat-
ing that the reduced brain size observed in adults (van der Lugt,
1994; Molofsky et al., 2003; Leung et al., 2004) is a defect of
postnatal development. After birth, we observed an important
impairment of body growth resulting, at 30 d of age, in a deficit of
50% in the knock-out mice compared with the Bmi1/mice
(9.5  0.7 and 20  0.4 g, respectively; n  3; p 	 0.001), con-
sistentwith previous results (van der Lugt et al., 1994;Molofsky et
al., 2003; Leung et al., 2004).
Bmi1 is expressed in nondifferentiated cells
To analyze the expression of Bmi1 in the newborn brain, we
performed an immunohistochemical staining with an antibody
directed against the Bmi1 protein on P0 brain slices from FVB
Bmi1/mice (no differences of Bmi1 expression were observed
between heterozygote and wild-type mice). Bmi1 was mainly ex-
pressed around the ventricles in the SVZ, the germinal zone of the
newborn brain (Fig. 1a–c). The majority of the Bmi1-positive
cells were located in the dorsomedial corner of the SVZ (47%;n
2 animals). Few positive cells were present in the cortex (9%).
Others (37%) formed a continuous chain of cells in the direction
of the septum. The remaining 6% were located in the rest of the
SVZ and in the corpus callosum.This pattern of expression shows
that Bmi1 is mainly expressed in regions known to contain NSCs
and multipotent precursors in mammalian brains (Morshead et
al., 1994; Doetsch et al., 1999; Arsenijevic et al., 2001a). To better
characterize Bmi1-expressing cells, we analyzed its expression in
neurospheres, knowing that such colonies contain both NSCs
and progenitor cells. In vitro, Bmi1 staining was observed in the
nucleus of undifferentiated cells (Fig. 1e), as well as in fewGFAP-
expressing cells (data not shown). The presence of Bmi1 in pro-
genitor cells was confirmed by RT-PCR analyses of Bmi1mRNAs
in cortical neurospheres (Fig. 1d). Neurospheres derived from
Bmi1/ mice were strongly positive for the presence of Bmi1
mRNAs (Fig. 1) (n  2 cell preparations). Moreover, when we
quantified the percentage of cells in a neurosphere able to gener-
ate newneurospheres and the percentage of cells expressing Bmi1
in the same neurosphere, we observed that the majority of the
cells express Bmi1 (59  5.6%) but only 17.5  3.5% can self-
renew (Fig. 1g).We observed an enhanced Bmi1 expressionwhen
the neurospheres were plated on fibronectin in the presence of
EGF (Fig. 1) (data not shown). Only rare cells did not express
Bmi1. Interestingly, spheres plated on the same substrate ex-
pressed markedly, and in numerous cells, the LeX carbohydrate
(supplemental Fig. 2, available at www.jneurosci.org as supple-
mental material) known to be present in NSCs and some other
progenitors (Capela and Temple, 2002). However, LeX expres-
sion is mainly restricted to the core of the neurosphere. More-
over, it appears that Bmi1 is expressed in both LeX-positive and
LeX-negative cells. These results suggest that although Bmi1 is
expressed in NSCs, its expression is not absolutely restricted to
Figure1. Bmi1 is expressed inprogenitor cells.a, c, Immunolabelingof theBmi1antigen (red) in thedorsomedial corner of the
SVZ of aBmi1/mouse.b, DAPI staining shows that Bmi1 is preferentially expressed in the germinal zone. VZ, Ventricular zone.
d, Bmi1 mRNA expression in cortical neurospheres of newborn Bmi1/ mice revealed by RT-PCR. Cx, Cortical neurospheres,
passage 2; St, embryonic striatal neurospheres, passage 2; C, control. Bmi1 is expressed by nondifferentiated progenitor cells.
After sphere growth, the sphere was plated onto fibronectin in the presence of EGF and fixed 24 h later. The great majority of
nestin-positive cells (green labeling) were also positive for the Bmi1 antigen (red). Arrows point to cells devoid of Bmi1 labeling
(e); the samecellswere counterstainedwithDAPI (blue; f ).g, Bmi1 is not a specificmarker of stemcells. Singleneurosphereswere
dissociated: one-half of the cells of each tested sphere were rapidly processed for Bmi1 immunolabeling, whereas the rest of the
cellswere tested for their ability to generate secondary neurospheres. The relationship between the number of generated spheres
and the number of Bmi1-positive cells is plotted in the graph in g. Magnification: a, b, 200; c, e, f, 400.
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NSCs but also occurs in a subpopulation of committed precursor
cells.
Bmi1 loss affects NSC/progenitor cell proliferation in vivo
We next investigated whether Bmi1 has an action on cortical
histogenesis, by controlling cell proliferation or apoptosis in vivo.
To test the first possibility, we quantified the number of prolifer-
ating cells in the brain at birth after giving newborn mice injec-
tions of the thymidine analog BrdU 30 min before being killed.
We analyzed the SVZ (Fig. 2a), the corpus callosum, and the
developing cortex (Fig. 2b) at four different locations, between
the septo-striatal and the septo-diencephalic sections (see Mate-
rials and Methods). We observed a significant reduction (by
64%) in BrdU-positive cells in the Bmi1/ cortex compared
with both Bmi1/ and Bmi1/ (Fig. 2c). The dorsolateral cor-
ner of the SVZ also presented a diminished proliferation com-
pared with heterozygous mice, but only a trend was observed
when compared with wild-type mice. Other regions investigated
(the SVZ and corpus callosum) did not show significant differ-
ences between genotypes (Fig. 2c). Note that no region showed a
significant variation between wild-type and Bmi1/ mice. P30
mice that received two injections of BrdU (at P28 and P29)
showed a significant decrease in BrdU cells in the Bmi1/
dorsolateral corner of the SVZ, a zone known to contain NSCs
and neural progenitors (Fig. 2d) (64.2  4.6 and 53.5  1.5
BrdU cells, respectively, in the control and Bmi1/ SVZ; p	
0.05; n 3 animals). Because the knock-out mice are two times
smaller at this stage, this decrease obviously disappears if one
presents the results in function of the animal size. The loss of
Bmi1 action may also have affected other developmental cues
such as cell survival. To quantify apoptotic cells, we investigated
the presence of the cells that had undergone DNA fragmentation
by performing the TUNEL assay. We analyzed the same regions
as for the BrdU incorporation but found no significant difference
between Bmi1/, Bmi1/, and Bmi1/ mice (supplemental
Fig. 3, available at www.jneurosci.org as supplemental material).
These results show that only a subpopulation of cells is affected by
Bmi1 loss in vivo during the perinatal period.However, the loss of
Bmi1 function produced a defect in proliferation, whichmaywell
explain the smaller brain size of the young Bmi1 knock-out mice
(van der Lugt et al., 1994; Molofsky et al., 2003; Leung et al.,
2004).
Effect of Bmi1 loss on NSC proliferation
Next we aimed to investigate whether the defect of cell prolifera-
tion in the cortex was linked to an impaired activity of NSCs as a
result ofBmi1 loss. To assess the quantity of corticalNSCs present
in Bmi1/, Bmi1/, and Bmi1/ mice, we used a standard
stem cell proliferation assay (Reynolds et al., 1992; Arsenijevic et
al., 2001b): at low cell density, NSCs proliferate in vitro in the
presence of EGF to form colonies termed neurospheres. Because
one neurosphere originates from one single cell, as demonstrated
previously by clonal analysis (Reynolds and Weiss, 1996) or by
culturing at low cell density (Tropepe et al., 1999), the number of
neurospheres obtained then allows estimating the number of
NSCs. Under EGF stimulation, cortical NSCs renew (at least 20
passages in our hands) and are multipotent, as described previ-
ously (Marmur et al., 1998). Cortical cells from the germinal zone
Figure 2. Analysis of cell proliferation in newborn brain as a function of Bmi1 expression.
Proliferating cells were identified using BrdU incorporation and analyzed in the cortex, the
corpus callosum, the SVZ, the dorsolateral corner of the SVZ, and the ventricular zone. a, b,
Anti-BrdU labeling (red) in the SVZ (a) and in the cortex (b) of a Bmi1/ mouse. Note that
proliferating cells are homogenously and densely distributed around the ventricle, whereas
dividing cells in the cortex are very dispersed. Magnification: a, 100; b, 200. c, Quantifica-
tion of the BrdU cells in the telencephalic regions described above (see Materials and Meth-
ods). WT, Wild type; HET, Bmi1/; KO, Bmi1/. The asterisk indicates the regions where a
significant differencewas observed between Bmi1/ and Bmi1/ or Bmi1/mice in the
cortex (n 3 Bmi1/mice; n 6 Bmi1/mice; n 6 Bmi1/mice; p 0.028) and
between Bmi1/ and Bmi1/ in the dorsomedial corner of the SVZ ( p 0.034). d, Quan-
tification of the BrdU cells in the dorsolateral corner of the adult SVZ (at P30; n 3; p	
0.05). *p	 0.05. CX, Cortex; CC, corpus callosum; SVZc, dorsolateral corner of the sub-
ventricular zone; VZ, ventricular zone; MZ, marginal zone; CTRL, control; KO, knock-out.
Error bars represent SEM.
Figure 3. Newborn Bmi1/ mice possess few NSCs. A stem cell proliferation assay was
applied to Bmi1/ and Bmi1/ newborn (a) or E14 (c) cerebral cortex primary cultures.
Note the decreased primary neurosphere formation capacity ofBmi1/ cortical cells. Second-
ary neurospheres formed from Bmi1/ and Bmi1/ dissociated single spheres (b, d) are
shown. Quantification of the effect of Bmi1 deletion on the cortical NSC renewal reveals a
markedly decreased capacity of sphere formation (b, d). a, c, The columns show the mean
number of neurospheres obtained from 5000 plated cells (n 4–6 animals per group) of P0
(PN0) and E14 mice, respectively. b, d, The columns show the mean number of secondary
neurospheres per dissociated primary neurosphere (n  30 primary neurospheres for
Bmi1/; n 19 for Bmi1/; n 41 for Bmi1/) of P0 and E14mice, respectively. *p
0.001; **p	 0.0001. WT, Wild type; HET, Bmi1/; KO, Bmi1/. Error bars represent SEM.
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to the mantle zone were isolated from newborn (P0) Bmi1/
mice and cultured at low density (see Materials and Methods) in
the presence of EGF. They gave rise to 10-foldmore neurospheres
than cells derived from the Bmi1/ cortex ( p  0.0001; n  4
animals for wild type and knock-out; n 6 animals forBmi1/)
(Fig. 3a). Note that Bmi1/ cultures behaved very similarly to
wild type. The majority of Bmi1/ spheres appeared within the
same time frame as Bmi1/ and Bmi1/ spheres. One month
after the initial sphere growth, fewBmi1/ spheres enlarged, but
themajority of the spheres remained at the same diminished size,
indicating that Bmi1 loss altered neurosphere formation and
NSC proliferation. This suggests that the number of NSCs in the
cerebral cortex is strongly depleted in the Bmi1/ animals. To
test this hypothesis, we isolated NSCs at E14, before the large
expansion of postnatal brain growth. Remarkably, Bmi1/ em-
bryos also presented fewer neurospheres in vitro compared with
heterozygous embryos [Bmi1/, 10  2 spheres per 5000 cells
(2  0.4 NSCs per 1000 primary cortical cells); Bmi1/, 0.6 
0.3 spheres per 5000 cells; p  0.005)] (Fig. 3c). Because the
cortex developed almost normally (see below) from E14 to P0,
this suggests that a compensatory signal may exist that helps to
maintain the NSC pool in vivo. Indeed, when primary E14
Bmi1/ cortical cells were cultivated at high density (150,000
cells/cm2), 5.6-fold more spheres were generated in vitro com-
pared with cells cultivated at low cell density (15,000 cells/cm2);
the frequency ofNSCs per 1000 primary cortical cells was, respec-
tively, 0.7 0.12 and 0.125 0.056 ( p 0.004; n 3 different
cultures). These experiments show that the high cell density en-
vironmentmight provide a signal of an as yet unknownmitogen/
survival or anti-stress factor, which could play a role in the atten-
uation of the phenotype observed in vivo. However, besides this
moderate rescue, the Bmi1/ EGF-responsive NSCs are still sig-
nificantly impaired even at these higher cell densities compared
withBmi1/NSCs (2 0.4NSCs per 1000 primary cortical cells
at low cell density).
Bmi1 is essential for cortical NSC renewal in vitro
To test the self-renewal capacity of P0 NSCs, single spheres were
dissociated and plated with EGF to form secondary neuro-
spheres. We observed a drastic decrease of self-renewal for
Bmi1/ neurospheres: although wild-type and heterozygous
primary neurospheres gave rise to a mean of 155 27 and 118
25 secondary neurospheres, respectively, Bmi1/ primary neu-
rospheres showed an almost complete failure to produce second-
ary neurospheres, with a mean of 0.2 0.12 per dissociated neu-
rosphere ( p 	 0.0001; n  30 neurospheres from four animals
for Bmi1/; n  19 neurospheres from four animals for
Bmi1/; n  41 neurospheres from six animals for Bmi1/)
(Fig. 3b). Moreover, the percentage of spheres able to renew is
markedly diminished in Bmi1/mice: only 10% of the spheres
generated a secondary sphere(s) compared with 87% for wild-
type and 83% for heterozygous spheres. We also observed that
both primary and secondary Bmi1/ neurospheres were smaller
(62  3.2 m; n  20) than those obtained from wild-type
(140 6.3 m; n 38) and heterozygous littermates (125 10
m; n  21). Similar results were obtained with E14 neuro-
spheres: one Bmi1/ neurosphere generated a mean of 115 
15.8 new spheres after dissociation (n  50 spheres from four
animals), and one Bmi1/ neurosphere generated a mean of
0.4 0.12 new spheres after dissociation (n 60; 4 animals; p	
0.0001) (Fig. 3d). Ninety-eight percent of Bmi1/ neurospheres
renew,whereas only 25%of theBmi1/neurospheres generated
secondary spheres. These results also show that E14 Bmi1/
cortical NSCs have a greater capacity to renew compared with P0
Bmi1/ NSCs (25% vs 10%).
Bmi1 acts on NSC in a cell-intrinsic mode
To further assess that Bmi1 directly controls stem cell renewal in
a cell-autonomousmanner, we infected neural progenitorswith a
lentivirus expressing a hairpin Bmi1-small interfering RNA
(siRNA) followed by a GFP marker transgene, to stably down-
regulate Bmi1mRNA levels. The siRNA lentivirus expressed the
transgene 48 h after infection, and here after plating, when the
first NSC divisions take place. When we infected low cell density
Bmi1/ cultures at passage 4, the Bmi1-siRNA reduced by 65%
the number ofmultipotent progenitors able to formnew colonies
(Fig. 4m) compared with control cells (GFP lentivirus). The
downregulation of Bmi1 protein expression was verified by im-
munocytochemistry on small spheres infected at 4 DIV and
checked 5 d later (Fig. 4a–h). The percentage of GFP-positive
cells expressing Bmi1 ranged from 48 to 49% in Bmi1-siRNA-
treated cultures and from 86 to 92% in control cultures infected
with a CMV (cytomegalovirus) promoter–GFP lentivirus. An-
nexin V staining showed that Bmi1-siRNA treatment did not
induce cell death compared with control treatments (Fig. 4i–l).
Reduction in the colony number formation was also observed
using antisense morpholinos (Fig. 4m). Together, these studies
demonstrate that Bmi1 intrinsically controls their self-renewal
capacity.
Bmi1 loss leads to an increase in GFAP astrocytes in vivo
at birth
We next investigated whether the cellular constitution of the
brain is affected by loss of Bmi1. In the perinatal cortex, NSCs
give rise mainly to astrocytes (Marmur et al., 1998; Levers et al.,
2001). Therefore, we performed anti-GFAP labeling to reveal the
astrocyte population. Newborn Bmi1/mice showed a stronger
GFAP expression and a fivefold higher number of GFAP-positive
cells than Bmi1/ in the marginal zone of the dorsal cortex
(46.5  12.9 and 9.3  4.3 astrocytes per section, respectively;
p  0.013; dorsal and temporal cortices together, 229.7  62.8
and 107  36.9 astrocytes per section, respectively in Bmi1/
and Bmi1/mice; p 0.087) (Fig. 5). The increased number of
astrocytes at birth led us to investigate whether it was attributable
to an early differentiation of neural progenitor cells into astro-
cytes, or if it was caused by increased progenitor proliferation.
We injected BrdU intraperitoneally into the pregnant mother at
E18, killed the pups at P0, and stained the brain slices for BrdU
and GFAP. We counted only the GFAP-positive astrocytes pre-
senting an identifiable nucleus, and we observed a strong colo-
calization of the two markers in both control and Bmi1/mice.
A total of 49.1 1.9 and 49.1 2.9% of the GFAP astrocytes in
the mantle zone were strongly BrdU, respectively (n  3 ani-
mals per genotype) (Fig. 5). Thus, although the number of the
astrocytes in the mantle zone at P0 was increased in Bmi1/
animals (Fig. 5), the percentage of proliferating GFAP-positive
cells appeared normal.
Bmi1/ animals present a GFAP gliosis at P30
The increased generation of astrocytes in the Bmi1/ brain at
birth led us to analyze the astroglial cell population at P30. The
number of GFAP cells increased dramatically during adult-
hood, giving rise to a generalized gliosis in Bmi1/ brains (Fig.
6d,i), which might be influenced by the presence of seizures (Ja-
cobs et al., 1999).We killed adult mice between P30 and P32 after
two daily BrdU injections. We counted GFAP cells that colo-
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calized clearly with a nucleus (DAPI stain-
ing) in three brain regions, including the
striatum, corpus callosum, and cortex in
both Bmi1/ and control mice. In all ar-
eas but the corpus callosum, the total
number of such astrocytes wasmuchmore
numerous in the knock-out mice (Fig. 6i).
Concerning proliferation, we found an in-
crease of 33.6 2.3% in the percentage of
proliferating GFAP cells in the Bmi1/
cortex compared with controls (n 3 an-
imals per genotype; p	 0.001) (Fig. 6e–h).
This indicates that glial precursors prolif-
erate normally or are even relatively en-
hanced in the absence ofBmi1, probably as
a response to brain damage. In contrast,
we observed no obvious difference in the
neuronal and oligodendrocytic cell popu-
lations, as revealed by NeuN and O4 label-
ing, respectively (data not shown), but fur-
ther characterization might be needed to
detect a potential discrete change. No ob-
vious changes in the pattern of cells ex-
pressing the nestin filament were observed
in newborn and adult brains (data not
shown), suggesting that generation of the
majority of undifferentiated committed
progenitor cells are not disturbed by the
absence of Bmi1 function. Indeed, nearly
all of the nestin-positive cells in the SVZ
are restricted progenitors, and NSCs rep-
resent only a very small subpopulation.
The loss of NSC pool in the knock-out
mice is consequently difficult to identify
and may also be hidden by the remaining
stem cells able to generate a normal num-
ber of progenitors. Moreover, some of
these progenitors may have a greater ca-
pacity to expand (evidenced by the in-
creased number of astrocytes). Together
with the BrdU incorporation data, these
observations suggest that astroglial pre-
cursors can proliferate in the absence of
Bmi1 in vivo.
Bmi1/ neurospheres generate
mainly astrocytes
After observing proliferation impairments
in vitro and in vivo, as well as the altered
cell pattern in vivo, we wanted to deter-
mine whether the rare Bmi1/ neuro-
spheres differentiate normally. In vitro dif-
ferentiation of E14 Bmi1/ spheres
revealed that cells remained mainly undif-
ferentiated in conditions known to induce
differentiation in wild-type spheres (lami-
nin plus FBS) and that themain phenotype
observed was astrocytic. Indeed, 100% of
the spheres (15 of 15) presented few
GFAP-positive cells and numerous cells
without any specific markers (Fig. 7).
-Tubulin-III-positive cells with a
neuronal-like immaturemorphologywere
Figure 4. Inhibition of Bmi1 expression by Bmi1-siRNA lentivirus prevents sphere formation. To assess whether Bmi1-siRNA
lentivirus blocks Bmi1 expression, small heterozygous spheres were infected with Bmi1-siRNA lentivirus or GFP lentivirus after a
growth of 4 DIV and then fixed 5 d later. a–d, Immunolabeling for Bmi1 (red; a) and GFP (green; b) after Bmi1-siRNA lentivirus
treatment. Note the reduction of Bmi1 labeling in the GFP-positive cell, infectedwith the lentivirus encoding the Bmi1-siRNA and
the GFP transgene, compared with the noninfected GFP-negative cell. c, DAPI staining of a and b. d, Merged image of a and b.
e–h, Immunolabeling for Bmi1 (red; e) and GFP (green; f ) after control GFP lentivirus treatment. Note that the GFP-positive cell
still expresses Bmi1 (h). g, DAPI staining of e and f. h, Merged image of e and f. i–l, Bmi1-siRNA lentivirus treatment does not
induce cell death, as assessed by GFP (expressed by cells infected with the Bmi1-siRNA lentivirus; see Materials andMethods and
Results) and annexin V staining. i, Annexin staining (red) on Bmi1-siRNA-treated cortical cell cultures. j, GFP staining (green). k,
DAPI staining of i and j. l, Merged image of i– k. Note that the GFP-positive cell is not stained by annexin V.Magnification, 400.
m, Dissociated cortical neurospheres infected with a Bmi1-siRNA lentivirus (0.3 or 1l of viral preparation, corresponding to 10
and 30 ng of p24, respectively) or incubated with Bmi1 antisense morpholinos (Morph.) (0.2 or 0.7 M) significantly reduced
neurosphere formation. *p	 0.05 and **p	 0.001 compared with control groups. RNAi, RNA interference.
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detected only in 3 of 15 spheres. Spheres derived from newborn
Bmi1/ mice also presented a loss of multipotency in standard
cell culture conditions: of 17 spheres plated on laminin plus 2%
FBS, 1 was multipotent, 2 contained neurons and astrocytes, 3
had astrocytes and oligodendrocytes, and 11 had only astrocytes.
For allBmi1/ spheres, few or several cells did not expressGFAP
or-tubulin-III: some of these cells expressed either nestin or the
S100 antigen with no overlap (data not shown). Seven of seven
spheres of heterozygous mice were multipotent on laminin.
These results indicate that differentiation of Bmi1/ spheres is
altered in vitro in standard conditions that normally allow wild-
type NSCs to generate glia and neurons.
Discussion
In this study, we report that the loss of Bmi1 causes a decrease in
proliferating cells in the cortex and the lateral corner of the SVZ at
birth as well as in the adult, likely related to a cell-intrinsic action
of Bmi1 in the control of NSC renewal. Our data also suggest that
an environmental factor(s) might compensate partially for Bmi1
loss. Additionally, we observed an increased astrocytic popula-
tion at birth and a generalized gliosis at P30. Interestingly, Bmi1
loss did not prevent astrocyte precursor proliferation, whereas
NSCs were affected.
In the adult brain, NSCs represent a relatively quiescent cell
population, whereas the actively proliferating cells are mostly
progenitors (Morshead et al., 1994). BrdU treatment for 2 d be-
fore being killed at P30 targets rather rapidly dividing progenitors
than slowly dividing stem cells (Maslov et al., 2004). Therefore,
the reduced BrdU incorporation in the Bmi1/ newborn cortex
and SVZ (after a 30min treatment) and in theBmi1/ adult SVZ
(after a 48 h treatment) evokes a decrease in a subpopulation of
cycling progenitor cells. This decrease is probably linked to the
progressive depletion of the NSC pool (Molofsky et al., 2003;
present study) and might explain the brain size reduction, which
is only detectable in young adult Bmi1/mice (van der Lugt et
al., 1994; Leung et al., 2004; our unpublished observations). The
reduced proliferation in the Bmi1/ SVZmight be related to the
upregulation of p16 ink4a and p19arf that is observed in the normal
brain and enhanced by the absence of Bmi1 (Molofsky et al.,
2003). Moreover, p19arf was recently shown to be a preferential
target for Bmi1 in the CNS (Bruggeman et al., 2005). Other CNS
regions could also be affected by Bmi1 loss and could be related to
the reduced brain size appearing postnatally. Accordingly, Leung
et al. (2004) have shown that the loss of Bmi1 also leads to a
depletion of proliferation capacity of cerebellar granule cell
precursors.
The decrease in proliferation in vivo is likely related to a di-
minished NSC pool, which would correlate with our data show-
ing a reduction of stem cell colony formation in vitro from corti-
cal cells derived from E14 Bmi1/ embryos and newborn mice.
The impact of Bmi1 loss on the capacity of NSCs to proliferate
and self-renewwas attenuatedwhenwe cultured E14 cortical cells
at high cell density. Likewise, the effect of Bmi1 loss on cell pro-
liferation in vivo is also reduced compared with neurosphere for-
mation in vitro. This suggests that an unidentified environmental
factor may partially compensate for Bmi1 loss in vivo and at high
cell density in vitro. Interestingly, the effect of cell density only
occurred in E14 cells, indicating that NSCs become more sensi-
tive to Bmi1 loss at the end of embryonic development. This also
suggests that the in vivo compensating signal is either lost or
downregulated during development.
Alternatively, it is possible that cells undergoing the culture
process were submitted to stress that could upregulate p16 ink4a
and/or p19arf, which are already derepressed in Bmi1/ cultures
because of the absence of its inhibitor Bmi1. This phenomenon
has been described in mouse and human embryonic fibroblasts
(Jacobs et al., 1999) and more recently in Bmi1/ NSCs
(Molofsky et al. 2003; Bruggeman et al., 2005). This would sug-
Figure 5. Bmi1/ mice present more astrocytes in the newborn dorsal cortex. a, c, d, f,
GFAP expression in heterozygousmice and in knock-outmice in themarginal zone of the dorsal
cortex. Note the increased number of astrocytes in Bmi1/mice. The white arrows show the
GFAP-positive cell location. The green arrows point to the pial edge. b, e, DAPI staining. g–j,
Colocalizazion of BrdU (red; g) and GFAP (green; h) in the marginal zone of a Bmi1/ cortex.
i, DAPI staining of g and h. j, Merged image of g and h. The insets show a detail of a GFAP- and
BrdU-positive cell, indicated by a white arrow. k, Quantification of the GFAP cells in the
marginal zone of the newborn dorsal cortex. Data are represented as absolute numbers of cells
per section. Error bars represent SEM. *p 0.01 compared with controls. HET, Heterozygous
mice; KO, knock-out mice; MZ, marginal zone; CTRL, control. Magnification: a, b, 100; d, e,
200; c, f, g–j, 400.
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gest that Bmi1/ NSCs are more sensitive to stress and could
explain why our data from low cell density cultures are more
pronounced compared with high-density cultures and in vivo
data. In agreement with our observations, progressive conse-
quences of Bmi1 loss on NSC proliferation during brain matura-
tion were also observed in the study by
Molofsky et al. (2003), but with a delayed
appearance of self-renewal failure. This
difference may be attributable to the dif-
ferent culture conditions (growth factors,
chick embryo extract, etc.) or to the differ-
ent genetic background of the knock-out
mice. Indeed, in their study, the effect of
Bmi1 loss onNSC renewal was observed to
be more pronounced at birth and during
adulthood than during embryogenesis. In
our study, by using more restrictive cul-
ture conditions using only EGF, we show
that Bmi1 affects proliferation and self-
renewal of the EGF-responsive NSCs, and
this effect already occurs at E14. Alto-
gether, these data suggest that the renewal
ability of NSCs becomes more dependent
on the presence of Bmi1 as brain develop-
ment progresses.
EGF is known to act directly on stem
cells, as shown by clonal analysis (Reyn-
olds and Weiss, 1996; Arsenijevic et al.,
2001b). The first NSC division in such cul-
ture conditions occurs only 72 h after plat-
ing. Because the siRNA lentivirus expressed
the transgene 48 h after infection, and given
that Bmi1--siRNA prevents sphere forma-
tion, these experiments are best compatible
with a cell-intrinsic effect of Bmi1 on NSC
renewal and not because of the stem cell
niche. As an alternative, Bmi1 loss may have
affected the daughter cells generated by the
stem cells that will prevent the NSCs from
proliferating. However, the experiments
with the siRNA-expressing lentivirus during
sphere growth and annexin V staining sug-
gest that the loss of Bmi1 did not induce
acute cell death, rendering this hypothesis
unlikely.However, the expression of Bmi1 is
also expressed in a subpopulation of neural
progenitor cells;we thereforecannotexclude
additional roles for Bmi1 on these cells.
With regard to the altered cell popula-
tion pattern of the Bmi1/ brain, the in-
creased glial population at P0 may be at-
tributable either to a change of NSC
responsiveness to environmental cues or a
premature differentiation of NSCs into as-
trocytes, the cells that they are pro-
grammed to form at birth. The BrdU in-
corporation assay clearly shows that
astrocyte precursors retain the ability to
proliferate in the absence ofBmi1. This ob-
servation is reinforced by the presence of
actively proliferating GFAP cells ob-
served at P30 in both knock-out and con-
trol animals, showing that astroglial pre-
cursors can proliferate even in theBmi1/ adult brain. Thus, the
increased number of astrocytes at birth cannot be linked to pre-
mature NSC differentiation because of cell cycle failure. It is,
however, not clear whether gliosis and the increased percentage
of proliferating astrocytes at P30 are attributable to a direct effect
Figure6. Bmi1/ adultmice have anormal cortical architecture but produce a stronggliosis.a,b, DAPI stainingof thedorsal
cortex at the septo-striatal level. c,d, GFAP labeling (red). Note thegliosis in theBmi1/brain.e–h, Colocalization of BrdU (red;
e) andGFAP (green; f ) in themarginal zone of theBmi1/ cortex.g, DAPI-stained nuclei.h, Merged image of e and f. Thewhite
arrows point out two GFAP astrocytes colocalizing with BrdU nuclei. i, Quantification of the GFAP cells in the adult (P30)
cortex. Data are represented as absolute numbers of cells per section for the corpus callosumandas absolute numbers per 10 fields
for the cortex and the striatum. Error bars represent SEM. *p	 0.05 compared with controls (n 3). PZ, Proliferating zone; IZ,
intermediate zone; SP, subplate; CP, cortical plate; MZ, marginal zone; CC, corpus callosum; St/Str, striatum; CX, cortex; KO,
knock-out; WT, wild type. Magnification: a–d, 100; e–h, 400.
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of Bmi1 loss or if they represent a side ef-
fect as a result of epilepsy and other neu-
rological problems displayed by Bmi1/
mice at this age. The increased number of
astrocytes at birth also correlates with the
in vitro differentiation data. In our study,
in standard conditions known to induce
NSC differentiation into neurons, astro-
cytes, and oligodendrocytes, the astrocyte
is also the most frequent cell phenotype
that appears in vitro after Bmi1/ sphere
differentiation. In contrast, Molofsky et al.
(2003) could obtain more multipotent
spheres, which could be attributable to the
more complex culture conditions used in
their study and to the different genetic
background of the mice. A possibility is that NSCs are almost
depleted. Consequently, the spheres obtained in our culture con-
ditions fromBmi1/ cortical cellsmay in part originate from the
rare glial progenitors able to proliferate in these conditions (Ar-
senijevic et al., 2001b), which would also explain their low re-
newal rate and the increased astrocyte number at birth. Never-
theless, our culture conditions also allowed rare multipotent and
bipotent Bmi1/ NSC/progenitor isolation and differentiation.
In contrast, the failure of Bmi1/ neurospheres to properly dif-
ferentiate could also be explained by a different capacity to re-
spond to environmental stimuli in vitro comparedwith wild-type
and heterozygous cells. This alteration appears to be partial, be-
cause other factors can compensate for this defect (Molofsky et
al., 2003). This compensatory phenomenon probably happens
almost constantly during brain development in vivo, as is sug-
gested by the almost normal formation of the telencephalon in
Bmi1 knock-out mice (Fig. 6b). Together, these data show that
Bmi1 loss does not affect the capacity of glial-restricted progeni-
tors to proliferate and suggest that Bmi1 action is specifically
required for the control of NSC proliferation in the telencepha-
lon. The requirement of Bmi1 for cerebellar granule cell precur-
sor proliferation, however, suggests that, in other brain areas,
Bmi1 action might not be limited to NSCs (Leung et al., 2004;
Bruggeman et al., 2005).
The present work shows that Bmi1 controls specifically NSC
renewal in a cell-autonomousmode but is not required for astro-
cyte precursor or glial progenitor proliferation. Interestingly, the
control of self-renewal versus differentiation decisions is not lim-
ited to theCNS but is also operational in hematopoietic stem cells
(Lessard and Sauvageau, 2003; Park et al., 2003), highlighting a
novel fundamental and conserved role for Bmi1/polycomb re-
pression. These Bmi1 functions bring new insights and a valuable
new key factor to study the generation of new neural cells during
adulthood (Altman andDas, 1965; Kempermann et al., 1997; van
Praag et al., 1999), and/or focal lesions (Magavi et al., 2000) or
ischemia (Nakatomi et al., 2002). However, an inducible system
is needed to bypass the problems linked to the epileptic status of
the young adult Bmi1/ mice. Such a model should also allow
study of the relevant Bmi1 target genes, anticipating important
implications for the development of regenerative therapies and
understanding of mechanisms controlling NSC renewal.
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